34.67USD-2.52%Mkt Cap: 3.66B USDP/E: —Last update: 2026-06-01
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The c…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.66B USD
Enterprise Value2.50B USD
Revenue (TTM)18.07M USD
Gross Profit6.62M USD
Net Income (TTM)-465.32M USD
Revenue/Share0.1870 USD
Last Price34.67 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees594
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS22663K1079
Valuation
P/E (Trailing)—
P/E (Forward)-8.45
PEG—
EV/EBITDA-4.63
EV/Revenue138.63
P/S207.45
P/B2.92
EPS (TTM)-5.14
EPS (Forward)-4.21
52W Range
25.8327% of range57.99
52W High57.99 USD
52W Low25.83 USD
Profitability
Gross Margin86.02%
Oper. Margin-1307.79%
EBITDA Margin0.00%
Profit Margin-6046.22%
ROE-46.90%
ROA-41.32%
Growth
Revenue Growth2873.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-377.92M USD
CapEx (TTM)5.76M USD
FCF Margin-1340.06%
FCF Yield-6.62%
Net Debt-1.24B USD
Net Debt/EBITDA2.30
Balance Sheet
Debt/Equity0.05
Current Ratio18.60
Quick Ratio18.25
Book Value/Sh12.16 USD
Cash/Share12.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)83.14 USD
Target Range55.00 USD – 97.00 USD
# Analysts14
Ownership
Shares Out.105.44M
Float95.58M
Insiders1.59%
Institutions120.03%
Short Interest
Short Ratio9.7d
Short % Float14.63%
Short % Out.12.50%
Shares Short13.18M
Short (prev mo.)12.80M
Technical
SMA 5037.77 (-8.2%)
SMA 20041.43 (-16.3%)
Beta0.28
S&P 52W Chg27.94%
Avg Vol (30d)1.17M
Avg Vol (10d)883.01K
Technical Indicators
RSI (14)41.4
MACD-0.7504
MACD Signal-0.6287
MACD Hist.-0.1217
BB Upper42.44 USD
BB Middle37.74 USD
BB Lower33.04 USD
BB Width24.90%
ATR (14)1.758 USD
Vol Ratio (20d)0.78x